ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Profession
Setting [clear]
Client Age [clear]
Topic Area [clear]
Experience
Course Format
SIG
Instructional Level [clear]
Results 41 - 50 of 83
Presenter(s): Dr. O’neil W. Guthrie, MS, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Gene therapy offers the promise to correct inherited forms of hearing loss as well as acquired forms such as noise-induced hearing loss, ototoxicity, and presbycusis. However, there are several barriers that must be overcome before such potential can be realized. This course describes the conceptual framework that governs gene therapy today, reveals how this framework has influenced current progress, and discusses a re-imagining of inner ear gene therapy with the goal of achieving outcomes that are clinically relevant and realistic.
Presenter(s): Vickie L. Tuten, AuD, CCC-A, CPS/A; Kathy E. Gates, AuD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Noise is prevalent in everyday life, and the general population lacks awareness of the risks of hazardous noise exposure and strategies to reduce noise-induced hearing loss. By integrating hearing loss prevention education into patient encounters and taking advantage of outreach/education opportunities, audiologists can help reduce the prevalence of noise-induced hearing loss. This course discusses the why, where, and how of integrating prevention education into your practice.
Presenter(s): Brooke Lang, MA, CCC-SLP; Kyle Mamiya, MS, CCC-SLP
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: SLPs across work settings face challenges associated with adapting their current evaluation and treatment methods to telepractice. This on demand webinar will discuss adaptations and evidence-based practices for using telepractice to effectively assess and treat individuals with neurogenic communication disorders.
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: This journal self-study course highlights the impacts of the COVID-19 pandemic on people with aphasia, patients with cognitive communication impairments, and patient-provider communication. The findings can inform decision-making and assist SLPs in optimizing treatment for communication challenges for patients with COVID-19 as well as those for whom treatment has been altered as a result of the pandemic.
Presenter(s): Dusty Jessen, AuD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: The provision of comprehensive auditory rehabilitation services is critical to successful patient outcomes, yet many audiologists focus primarily or exclusively on amplification due to time, reimbursement, and compliance challenges. This session will clearly define the components of auditory rehabilitation and provide specific strategies and tools to help overcome challenges.
Presenter(s): Meaghan Reed, AuD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: It is unclear how over-the-counter hearing devices will impact our patients and our practices in the coming years. This session will discuss practical strategies for incorporating OTC devices, deciding when to offer alternative rehabilitation options to patients, and offering a wider variety of solutions to meet our patients’ needs.
Presenter(s): Dave Fabry, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: There is no question that emerging technologies such as embedded sensors and artificial intelligence are changing the hearing health landscape. This session will look ahead to the coming decade and explore innovations in hearing health care technology, strategy, and service. The speaker will discuss practical ways to leverage these innovations to be successful in today’s and tomorrow’s dynamic market landscape.
Presenter(s): Amy Wright, MCD, CCC-SLP
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: When individuals with amyotrophic lateral sclerosis (ALS) experience changes in speech, they often look to SLPs for guidance and hope. SLPs have many tools at their disposal that can make a dramatic difference in patients’ quality of life. This on demand webinar will describe practical, patient-focused methods for AAC assessment and implementation for individuals with ALS that are based on an individual’s current strengths and needs.
Presenter(s): Brent E. Archer, PhD, CCC-SLP, LSVT Certified; Jamie Azios, PhD, CCC-SLP; Suma Devanga, PhD, CCC-SLP; Julie A. Hengst, PhD, CCC-SLP; Marion C. Leaman, PhD, CCC-SLP; Paul Prior, PhD; et al.
Credit(s): PDHs: 1.5, ASHA CEUs*: 0.15
Summary: This course explores Innovating & Situating Practice in Rich Environments (InSPiRE), a novel approach to aphasia intervention. InSPiRE works with clinicians to recognize discourse patterns typical of restricted and rich environments and to apply discourse practices strategically, both to enrich clinical activities and to promote improved communication between individuals with aphasia and their everyday communication partners. The speakers discuss interactional research and practical strategies for topic management, contingent responses, shaping conversational narratives, creative use of collaborative referencing techniques, and other methods for creating rich communicative environments. This course – part of the SIGnature Series – was developed by SIG 2: Neurogenic Communication Disorders.
Presenter(s): Cynthia Hogan,PhD, CCC-A; Janalene Jacobson,AuD, CCC-A; Melanie Meldrum,AuD, CCC-A; Sarah Ostlie, AuD, CCC-A
Credit(s): PDHs: 1.5, ASHA CEUs*: 0.15
Summary: This course explores the most commonly fit devices for patients whose hearing is significantly poorer in one ear than the other (e.g., single-sided deafness or asymmetric hearing loss) and identify factors that impact device selection and hearing management. Using data analysis and case examples from their clinic, the speakers discuss management options for asymmetrical sensorineural hearing loss, including traditional hearing aids, Bi-CROS devices, bone conduction devices (BCD), and cochlear implants (all with or without assistive devices).This course – part of the SIGnature Series – was developed by SIG 6: Hearing and Hearing Disorders: Research and Diagnostics.
<< 1 2 3 4 5 6 7 8 9 >>